OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
MDKI56

Emdeki Utama Tbk PT

Commodity ChemicalsVerified

Emdeki Utama Tbk PT maintains a strong liquidity position, with a current ratio of 4.98, indicating that the company holds nearly five times more current assets than current liabilities. The company's liquidity is further supported by a high cash and equivalents balance of IDR 170.47 billion, which provides a buffer against short-term obligations. The debt-to-equity ratio of 0.01 suggests a conservative capital structure, with minimal reliance on debt financing. Profitability metrics for Emdeki Utama Tbk PT are modest, with a return on equity (ROE) of 0.27% and a return on assets (ROA) of 0.23%. These figures are below the typical thresholds for the Commodity Chemicals industry, which often sees ROE and ROA in the 2-5% range. The company's net income of IDR 2.48 billion is derived from a gross profit of IDR 12.94 billion, with operating income of IDR 4.34 billion. These figures suggest that the company is generating profits but at a relatively low margin. Emdeki Utama Tbk PT's revenue is concentrated in a single business segment, as disclosed in its financial reports. The company does not provide detailed geographic breakdowns of its revenue, but it is primarily focused on the domestic Indonesian market. This concentration may expose the company to regional economic fluctuations and regulatory changes. The company's growth trajectory appears to be stable, with a revenue of IDR 64.48 billion in the latest reporting period. While no specific growth rate is provided, the company's operating cash flow of IDR 8.34 billion and free cash flow of IDR 2.69 billion indicate a capacity to fund operations and potentially reinvest in the business. The capital expenditure of IDR -7.36 billion suggests that the company is not currently investing heavily in new projects or expansions. Risk factors for Emdeki Utama Tbk PT are currently low, with no immediate filing-based liquidity or dilution flags detected. The company's low debt-to-equity ratio and high cash reserves reduce the risk of financial distress. However, the company's reliance on a single business segment and geographic concentration could pose long-term risks if market conditions change. Recent events and filings for Emdeki Utama Tbk PT do not indicate any significant changes in the company's operations or financial strategy. The company has not issued any new shares or taken on additional debt in the latest reporting period, and there are no indications of upcoming regulatory challenges or operational disruptions.

30-day price · MDKI+0.00 (+0.0%)
Low$181.00High$206.00Close$191.00As of13 May, 00:00 UTC
Profile
CompanyEmdeki Utama Tbk PT
TickerMDKI.JK
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Emdeki Utama Tbk PT is a chemical manufacturing company that produces and distributes commodity chemicals, primarily generating revenue through the sale of chemical products to industrial and commercial customers.

Classification. Emdeki Utama Tbk PT is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a confidence level of 0.92 based on verified market data.

Emdeki Utama Tbk PT maintains a strong liquidity position, with a current ratio of 4.98, indicating that the company holds nearly five times more current assets than current liabilities. The company's liquidity is further supported by a high cash and equivalents balance of IDR 170.47 billion, which provides a buffer against short-term obligations. The debt-to-equity ratio of 0.01 suggests a conservative capital structure, with minimal reliance on debt financing. Profitability metrics for Emdeki Utama Tbk PT are modest, with a return on equity (ROE) of 0.27% and a return on assets (ROA) of 0.23%. These figures are below the typical thresholds for the Commodity Chemicals industry, which often sees ROE and ROA in the 2-5% range. The company's net income of IDR 2.48 billion is derived from a gross profit of IDR 12.94 billion, with operating income of IDR 4.34 billion. These figures suggest that the company is generating profits but at a relatively low margin. Emdeki Utama Tbk PT's revenue is concentrated in a single business segment, as disclosed in its financial reports. The company does not provide detailed geographic breakdowns of its revenue, but it is primarily focused on the domestic Indonesian market. This concentration may expose the company to regional economic fluctuations and regulatory changes. The company's growth trajectory appears to be stable, with a revenue of IDR 64.48 billion in the latest reporting period. While no specific growth rate is provided, the company's operating cash flow of IDR 8.34 billion and free cash flow of IDR 2.69 billion indicate a capacity to fund operations and potentially reinvest in the business. The capital expenditure of IDR -7.36 billion suggests that the company is not currently investing heavily in new projects or expansions. Risk factors for Emdeki Utama Tbk PT are currently low, with no immediate filing-based liquidity or dilution flags detected. The company's low debt-to-equity ratio and high cash reserves reduce the risk of financial distress. However, the company's reliance on a single business segment and geographic concentration could pose long-term risks if market conditions change. Recent events and filings for Emdeki Utama Tbk PT do not indicate any significant changes in the company's operations or financial strategy. The company has not issued any new shares or taken on additional debt in the latest reporting period, and there are no indications of upcoming regulatory challenges or operational disruptions.
Key takeaways
  • Emdeki Utama Tbk PT has a strong liquidity position with a current ratio of 4.98 and a high cash and equivalents balance.
  • The company's profitability is modest, with ROE and ROA below industry norms.
  • Revenue is concentrated in a single business segment, with no detailed geographic breakdown provided.
  • Growth appears stable, supported by positive operating and free cash flows.
  • Risk factors are currently low, with no immediate liquidity or dilution concerns.
  • The company's conservative capital structure and low debt-to-equity ratio reduce financial risk.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyIDR
Revenue$64.48B
Gross profit$12.94B
Operating income$4.34B
Net income$2.48B
R&D
SG&A
D&A
SBC
Operating cash flow$8.34B
CapEx-$7.36B
Free cash flow$2.69B
Total assets$1.06T
Total liabilities$127.54B
Total equity$931.09B
Cash & equivalents$170.47B
Long-term debt$12.42B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$397.31B$49.22B$38.71B$17.45B
FY-3$486.88B$55.16B$37.95B$8.19B
FY-2$470.70B$65.19B$47.80B$34.68B
FY-1$344.46B$41.28B$27.55B$5.57B
FY0$319.17B$48.40B$34.41B-$26.14B
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$985.40B$891.63B$161.80B
FY-3$1.05T$925.77B$143.60B
FY-2$1.06T$950.09B$170.69B
FY-1$1.04T$958.75B$179.52B
FY0$1.06T$974.41B$174.94B
PeriodOCFCapExFCFSBC
FY-4$29.84B-$6.35B$17.45B
FY-3-$506.0M-$19.94B$8.19B
FY-2$65.73B-$5.44B$34.68B
FY-1$60.60B-$10.46B$5.57B
FY0$97.42B-$60.26B-$26.14B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$64.48B$4.34B$2.48B$2.69B
FQ-6$93.95B$11.13B$7.92B$10.71B
FQ-5$101.01B$13.40B$8.29B$12.78B
FQ-4$73.63B$14.37B$10.02B$14.32B
FQ-3$77.78B$10.81B$7.80B$192.0M
FQ-2$78.37B$8.52B$6.26B-$21.65B
FQ-1$89.40B$14.70B$10.34B$1.23B
FQ0$71.58B$8.76B$6.30B$2.28B
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$1.06T$931.09B$170.47B
FQ-6$1.03T$939.08B$173.43B
FQ-5$1.04T$958.75B$179.52B
FQ-4$1.05T$968.70B$178.97B
FQ-3$1.04T$956.25B$195.97B
FQ-2$1.05T$962.57B$176.07B
FQ-1$1.06T$974.41B$174.94B
FQ0$1.06T$980.69B$171.24B
PeriodOCFCapExFCFSBC
FQ-7$8.34B-$7.36B$2.69B
FQ-6$15.83B-$9.40B$10.71B
FQ-5$60.60B-$10.46B$12.78B
FQ-4$19.10B-$791.0M$14.32B
FQ-3$31.81B-$13.05B$192.0M
FQ-2$54.16B-$45.74B-$21.65B
FQ-1$97.42B-$60.26B$1.23B
FQ0$12.45B-$9.93B$2.28B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$931.09B
Net cash$158.05B
Current ratio5.0
Debt/Equity0.0
ROA0.2%
ROE0.3%
Cash conversion3.4%
CapEx/Revenue-11.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricMDKIActivity
Op margin6.7%5.5% medp25 -0.0% · p75 10.8%above median
Net margin3.9%4.1% medp25 0.1% · p75 8.8%below median
Gross margin20.1%20.5% medp25 12.4% · p75 29.7%below median
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-11.4%-6.2% medp25 -13.4% · p75 -2.6%below median
Debt / equity1.0%37.1% medp25 10.3% · p75 82.0%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-08 06:27 UTC#ab659557
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 13:05 UTCJob: bdbdaffd